Vicore Pharma (Sweden) Probability of Future Stock Price Finishing Under 8.42

VICO Stock  SEK 7.92  0.32  3.88%   
Vicore Pharma's future price is the expected price of Vicore Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vicore Pharma Holding performance during a given time horizon utilizing its historical volatility. Check out Vicore Pharma Backtesting, Vicore Pharma Valuation, Vicore Pharma Correlation, Vicore Pharma Hype Analysis, Vicore Pharma Volatility, Vicore Pharma History as well as Vicore Pharma Performance.
  
Please specify Vicore Pharma's target price for which you would like Vicore Pharma odds to be computed.

Vicore Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vicore Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vicore Pharma Holding can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vicore Pharma had very high historical volatility over the last 90 days
Vicore Pharma has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (296.48 M) with profit before overhead, payroll, taxes, and interest of 0.
Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1.
Roughly 16.0% of the company outstanding shares are owned by insiders

Vicore Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vicore Stock often depends not only on the future outlook of the current and potential Vicore Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vicore Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding69.7 M
Cash And Short Term Investments371.2 M

Vicore Pharma Technical Analysis

Vicore Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Vicore Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vicore Pharma Holding. In general, you should focus on analyzing Vicore Stock price patterns and their correlations with different microeconomic environments and drivers.

Vicore Pharma Predictive Forecast Models

Vicore Pharma's time-series forecasting models is one of many Vicore Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vicore Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Vicore Pharma Holding

Checking the ongoing alerts about Vicore Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vicore Pharma Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vicore Pharma had very high historical volatility over the last 90 days
Vicore Pharma has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (296.48 M) with profit before overhead, payroll, taxes, and interest of 0.
Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1.
Roughly 16.0% of the company outstanding shares are owned by insiders

Additional Tools for Vicore Stock Analysis

When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.